DYN icon

Dyne Therapeutics

113 hedge funds and large institutions have $571M invested in Dyne Therapeutics in 2022 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 37 increasing their positions, 34 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more ownership

Funds ownership:

9% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 34

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

0% less capital invested

Capital invested by funds: $573M → $571M (-$1.79M)

Holders
113
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$860K
Puts
$49K
Net Calls
Net Calls Change

Top Buyers

1 +$26.9M
2 +$10.8M
3 +$5.81M
4
Goldman Sachs
Goldman Sachs
New York
+$5.08M
5
Axa
Axa
France
+$4.27M

Top Sellers

1 -$19.5M
2 -$5.79M
3 -$2.24M
4
LGM
Logos Global Management
California
-$1.59M
5
Citigroup
Citigroup
New York
-$1.35M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$570K
52
$464K
53
$461K
54
$453K
55
$421K
56
$415K
57
$409K
58
$407K
59
$387K
60
$341K
61
$326K
62
$288K
63
$282K
64
$269K
65
$256K
66
$237K
67
$229K
68
$228K
69
$213K
70
$213K
71
$207K
72
$198K
73
$197K
74
$195K
75
$180K